Previous Article | Next Article 
Clinical Microbiology Reviews, April 2006, p. 338-381, Vol. 19, No. 2
0893-8512/06/$08.00+0 doi:10.1128/CMR.19.2.338-381.2006
The Continuing Challenges of Leprosy
D. M. Scollard,*
L. B. Adams,
T. P. Gillis,
J. L. Krahenbuhl,
R. W. Truman, and
D. L. Williams
Laboratory
Research Branch, National Hansen's Disease Programs, Louisiana
State University-SVM, Baton Rouge, Louisiana 70803
Leprosy is best understood as two conjoined diseases. The first is a
chronic mycobacterial infection that elicits an extraordinary range of
cellular immune responses in humans. The second is a peripheral
neuropathy that is initiated by the infection and the accompanying
immunological events. The infection is curable but not preventable, and
leprosy remains a major global health problem, especially in the
developing world, publicity to the contrary notwithstanding.
Mycobacterium leprae remains noncultivable, and for over a
century leprosy has presented major challenges in the fields of
microbiology, pathology, immunology, and genetics; it continues to do
so today. This review focuses on recent advances in our understanding
of M. leprae and the host response to it, especially
concerning molecular identification of M. leprae, knowledge of
its genome, transcriptome, and proteome, its mechanisms of microbial
resistance, and recognition of strains by variable-number tandem repeat
analysis. Advances in experimental models include studies in gene
knockout mice and the development of molecular techniques to explore
the armadillo model. In clinical studies, notable progress has been
made concerning the immunology and immunopathology of leprosy, the
genetics of human resistance, mechanisms of nerve injury, and
chemotherapy. In nearly all of these areas, however, leprosy remains
poorly understood compared to other major bacterial
diseases.
* Corresponding
author. Mailing address: Laboratory Research Branch, National Hansen's Disease Programs, LSU-SVM, Skip Bertman Dr., Baton Rouge, LA 70803. Phone: (225) 578-9841. Fax: (225) 578-9856. E-mail:
dscoll1{at}lsu.edu.
Clinical Microbiology Reviews, April 2006, p. 338-381, Vol. 19, No. 2
0893-8512/06/$08.00+0 doi:10.1128/CMR.19.2.338-381.2006
This article has been cited by other articles:
-
Elias, J. Jr, Nogueira-Barbosa, M. H., Feltrin, L. T., Furini, R. B., Foss, N. T., Marques, W. Jr, dos Santos, A. C.
(2009). Role of Ulnar Nerve Sonography in Leprosy Neuropathy With Electrophysiologic Correlation. J Ultrasound Med
28: 1201-1209
[Abstract]
[Full Text]
-
Lini, N., Shankernarayan, N. P., Dharmalingam, K.
(2009). Quantitative real-time PCR analysis of Mycobacterium leprae DNA and mRNA in human biopsy material from leprosy and reactional cases. J Med Microbiol
58: 753-759
[Abstract]
[Full Text]
-
Hagge, D. A., Saunders, B. M., Ebenezer, G. J., Ray, N. A., Marks, V. T., Britton, W. J., Krahenbuhl, J. L., Adams, L. B.
(2009). Lymphotoxin-{alpha} and TNF Have Essential but Independent Roles in the Evolution of the Granulomatous Response in Experimental Leprosy. Am. J. Pathol.
174: 1379-1389
[Abstract]
[Full Text]
-
Duthie, M. S., Goto, W., Ireton, G. C., Reece, S. T., Sampaio, L. H., Grassi, A. B., Sousa, A. L. M., Martelli, C. M. T., Stefani, M. M. A., Reed, S. G.
(2008). Antigen-Specific T-Cell Responses of Leprosy Patients. CVI
15: 1659-1665
[Abstract]
[Full Text]
-
Matrat, S., Cambau, E., Jarlier, V., Aubry, A.
(2008). Are All the DNA Gyrase Mutations Found in Mycobacterium leprae Clinical Strains Involved in Resistance to Fluoroquinolones?. Antimicrob. Agents Chemother.
52: 745-747
[Abstract]
[Full Text]
-
Sapkota, B. R., Ranjit, C., Neupane, K. D., Macdonald, M.
(2008). Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae. J Med Microbiol
57: 179-184
[Abstract]
[Full Text]
-
Duthie, M. S., Reece, S. T., Lahiri, R., Goto, W., Raman, V. S., Kaplan, J., Ireton, G. C., Bertholet, S., Gillis, T. P., Krahenbuhl, J. L., Reed, S. G.
(2007). Antigen-Specific Cellular and Humoral Responses Are Induced by Intradermal Mycobacterium leprae Infection of the Mouse Ear. Infect. Immun.
75: 5290-5297
[Abstract]
[Full Text]
-
Saha, S., Mondal, S., Ravindran, R., Bhowmick, S., Modak, D., Mallick, S., Rahman, M., Kar, S., Goswami, R., Guha, S. K., Pramanik, N., Saha, B., Ali, N.
(2007). IL-10- and TGF-beta-Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India. J. Immunol.
179: 5592-5603
[Abstract]
[Full Text]
-
Mendonca, V. A., Malaquias, L. C., Brito-Melo, G. E., Castelo-Branco, A., Antunes, C. M., Ribeiro, A. L., Teixeira, M. M., Teixeira, A. L.
(2007). Differentiation of Patients with Leprosy from Non-Infected Individuals by the Chemokine Eotaxin/CCL11. Am J Trop Med Hyg
77: 547-550
[Abstract]
[Full Text]
-
Matrat, S., Petrella, S., Cambau, E., Sougakoff, W., Jarlier, V., Aubry, A.
(2007). Expression and Purification of an Active Form of the Mycobacterium leprae DNA Gyrase and Its Inhibition by Quinolones. Antimicrob. Agents Chemother.
51: 1643-1648
[Abstract]
[Full Text]
-
Fenollar, F., Puechal, X., Raoult, D.
(2007). Whipple's Disease. NEJM
356: 55-66
[Full Text]